|
EIF2AK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.586400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.783300E-03 |
| Normal-vs-Stage2 |
5.692800E-01 |
| Normal-vs-Stage3 |
4.320000E-01 |
| Normal-vs-Stage4 |
8.462800E-01 |
| Stage1-vs-Stage2 |
2.661000E-01 |
| Stage1-vs-Stage3 |
2.524000E-01 |
| Stage1-vs-Stage4 |
1.118980E-01 |
| Stage2-vs-Stage3 |
9.305000E-01 |
| Stage2-vs-Stage4 |
5.865600E-01 |
| Stage3-vs-Stage4 |
5.052400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.112400E-02 |
| Normal-vs-AfricanAmerican |
3.711000E-01 |
| Normal-vs-Asian |
8.075400E-01 |
| Caucasian-vs-AfricanAmerican |
2.410400E-01 |
| Caucasian-vs-Asian |
3.279800E-01 |
| AfricanAmerican-vs-Asian |
5.845600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.577200E-03 |
| Normal-vs-Female |
4.420200E-01 |
| Male-vs-Female |
2.29059999999892E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.239800E-01 |
| Normal-vs-Extreme_Weight |
1.227580E-02 |
| Normal-vs-Obese |
8.292200E-02 |
| Normal-vs-Extreme_Obese |
2.392300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.473700E-02 |
| Normal_Weight-vs-Obese |
2.369600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.737180E-01 |
| Extreme_Weight-vs-Obese |
4.100000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.242600E-01 |
| Obese-vs-Extreme_Obese |
3.515400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.151600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.236000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.618600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.109820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.526160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.385900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.208160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.534200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.987600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.195000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.239160E-03 |
| Normal-VS-Type2 PRCC |
2.177700E-02 |
| Normal-VS-KIRP CIMP |
4.14460000000005E-05 |
| Normal-VS-Unclassified PRCC |
6.672000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.809800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.99924537930474E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
4.558100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.94069999998248E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.365040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.162500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.284300E-03 |
| Normal-vs-N1 |
9.081200E-01 |
| Normal-vs-N2 |
6.285000E-01 |
| N0-vs-N1 |
4.465600E-02 |
| N0-vs-N2 |
5.049800E-01 |
| N1-vs-N2 |
6.964800E-01 |
|
|
